Ontex launches NEW men’s pants range  

Date:

Share post:

Incontinence experts Ontex have launched their new iD for Men Level 4 pants.

Providing extreme comfort and a perfect fit, the all-round stretch, elastified material has a thin and flexible core to ensure that the pants fit like real underwear, perfect for carrying on with day to day activities. The pant has been designed to stay in place, not lose its shape or become bulky even when saturated.

Thanks to the cotton-like material used on both the inside and out, it feels soft, all day long, so you won’t know you’re wearing an incontinence pant. This fully breathable material means a healthy skin and no sweating.

Ontex exclusively specialises in products for continence management, including products for light, moderate and heavy incontinence in a range of unisex, female, male and junior styles. The products offer odour control and fast absorption, keeping liquid locked in the pad as well as anti-leakage protection.

iD Men Level 4 come in a size Medium and Large and are available from id-direct.com, ASDA pharmacy and local pharmacies priced at £8.99 only.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...